Loading…
SERS Immunosensors for Cancer Markers Detection
Early diagnosis and monitoring are essential for the effective treatment and survival of patients with different types of malignancy. To this end, the accurate and sensitive determination of substances in human biological fluids related to cancer diagnosis and/or prognosis, i.e., cancer biomarkers,...
Saved in:
Published in: | Materials 2023-05, Vol.16 (10), p.3733 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c474t-e6e2c11bdf18fa33aa9f2a7a05e6d818f9bffb91e566afde12335902ab5180d73 |
---|---|
cites | cdi_FETCH-LOGICAL-c474t-e6e2c11bdf18fa33aa9f2a7a05e6d818f9bffb91e566afde12335902ab5180d73 |
container_end_page | |
container_issue | 10 |
container_start_page | 3733 |
container_title | Materials |
container_volume | 16 |
creator | Geka, Georgia Kanioura, Anastasia Likodimos, Vlassis Gardelis, Spiros Papanikolaou, Nikolaos Kakabakos, Sotirios Petrou, Panagiota |
description | Early diagnosis and monitoring are essential for the effective treatment and survival of patients with different types of malignancy. To this end, the accurate and sensitive determination of substances in human biological fluids related to cancer diagnosis and/or prognosis, i.e., cancer biomarkers, is of ultimate importance. Advancements in the field of immunodetection and nanomaterials have enabled the application of new transduction approaches for the sensitive detection of single or multiple cancer biomarkers in biological fluids. Immunosensors based on surface-enhanced Raman spectroscopy (SERS) are examples where the special properties of nanostructured materials and immunoreagents are combined to develop analytical tools that hold promise for point-of-care applications. In this frame, the subject of this review article is to present the advancements made so far regarding the immunochemical determination of cancer biomarkers by SERS. Thus, after a short introduction about the principles of both immunoassays and SERS, an extended presentation of up-to-date works regarding both single and multi-analyte determination of cancer biomarkers is presented. Finally, future perspectives on the field of SERS immunosensors for cancer markers detection are briefly discussed. |
doi_str_mv | 10.3390/ma16103733 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10221005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A750991553</galeid><sourcerecordid>A750991553</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-e6e2c11bdf18fa33aa9f2a7a05e6d818f9bffb91e566afde12335902ab5180d73</originalsourceid><addsrcrecordid>eNptkVtr3DAQhUVpaEKyL_kBZaEvpbCJRmPZ1lMJmyskBLrNs5DlUerUllLJLuTfR8vmWio9SBx9c8TMYWwf-AGi4oeDgRI4Vogf2A4oVS5AFcXHN_dtNkvpjueFCLVQn9g2VqIALPkOO1yd_FjNL4Zh8iGRTyGmuQtxvjTeUpxfmfibsnRMI9mxC36PbTnTJ5o9nbvs5vTk5_J8cXl9drE8ulzYoirGBZUkLEDTOqidQTRGOWEqwyWVbZ011TjXKCBZlsa1BAJRKi5MI6HmbYW77PvG935qBmot-TGaXt_HbjDxQQfT6fcvvvulb8NfDVwI4Fxmh69PDjH8mSiNeuiSpb43nsKUtKgF51CUFc_ol3_QuzBFn_vLVB5hJWuEV-rW9KQ770L-2K5N9VEluVIgJWbq4D9U3i0NnQ2eXJf1dwXfNgU2hpQiuZcmget1xPo14gx_fjuWF_Q5UHwEgF2eQA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2819475831</pqid></control><display><type>article</type><title>SERS Immunosensors for Cancer Markers Detection</title><source>Full-Text Journals in Chemistry (Open access)</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Geka, Georgia ; Kanioura, Anastasia ; Likodimos, Vlassis ; Gardelis, Spiros ; Papanikolaou, Nikolaos ; Kakabakos, Sotirios ; Petrou, Panagiota</creator><creatorcontrib>Geka, Georgia ; Kanioura, Anastasia ; Likodimos, Vlassis ; Gardelis, Spiros ; Papanikolaou, Nikolaos ; Kakabakos, Sotirios ; Petrou, Panagiota</creatorcontrib><description>Early diagnosis and monitoring are essential for the effective treatment and survival of patients with different types of malignancy. To this end, the accurate and sensitive determination of substances in human biological fluids related to cancer diagnosis and/or prognosis, i.e., cancer biomarkers, is of ultimate importance. Advancements in the field of immunodetection and nanomaterials have enabled the application of new transduction approaches for the sensitive detection of single or multiple cancer biomarkers in biological fluids. Immunosensors based on surface-enhanced Raman spectroscopy (SERS) are examples where the special properties of nanostructured materials and immunoreagents are combined to develop analytical tools that hold promise for point-of-care applications. In this frame, the subject of this review article is to present the advancements made so far regarding the immunochemical determination of cancer biomarkers by SERS. Thus, after a short introduction about the principles of both immunoassays and SERS, an extended presentation of up-to-date works regarding both single and multi-analyte determination of cancer biomarkers is presented. Finally, future perspectives on the field of SERS immunosensors for cancer markers detection are briefly discussed.</description><identifier>ISSN: 1996-1944</identifier><identifier>EISSN: 1996-1944</identifier><identifier>DOI: 10.3390/ma16103733</identifier><identifier>PMID: 37241360</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antibodies ; Antigens ; Biomarkers ; Biosensors ; Cancer ; Care and treatment ; Diagnosis ; Electromagnetism ; Immunosensors ; Laboratories ; Light ; Nanomaterials ; Nanoparticles ; Nanostructured materials ; Radiation ; Raman spectroscopy ; Raman, Chandrasekhara V ; Review ; Spectrum analysis ; Tumor markers</subject><ispartof>Materials, 2023-05, Vol.16 (10), p.3733</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-e6e2c11bdf18fa33aa9f2a7a05e6d818f9bffb91e566afde12335902ab5180d73</citedby><cites>FETCH-LOGICAL-c474t-e6e2c11bdf18fa33aa9f2a7a05e6d818f9bffb91e566afde12335902ab5180d73</cites><orcidid>0000-0002-4288-6132 ; 0000-0002-0102-769X ; 0000-0001-8340-8025 ; 0000-0002-0043-3119</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2819475831/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2819475831?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37241360$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Geka, Georgia</creatorcontrib><creatorcontrib>Kanioura, Anastasia</creatorcontrib><creatorcontrib>Likodimos, Vlassis</creatorcontrib><creatorcontrib>Gardelis, Spiros</creatorcontrib><creatorcontrib>Papanikolaou, Nikolaos</creatorcontrib><creatorcontrib>Kakabakos, Sotirios</creatorcontrib><creatorcontrib>Petrou, Panagiota</creatorcontrib><title>SERS Immunosensors for Cancer Markers Detection</title><title>Materials</title><addtitle>Materials (Basel)</addtitle><description>Early diagnosis and monitoring are essential for the effective treatment and survival of patients with different types of malignancy. To this end, the accurate and sensitive determination of substances in human biological fluids related to cancer diagnosis and/or prognosis, i.e., cancer biomarkers, is of ultimate importance. Advancements in the field of immunodetection and nanomaterials have enabled the application of new transduction approaches for the sensitive detection of single or multiple cancer biomarkers in biological fluids. Immunosensors based on surface-enhanced Raman spectroscopy (SERS) are examples where the special properties of nanostructured materials and immunoreagents are combined to develop analytical tools that hold promise for point-of-care applications. In this frame, the subject of this review article is to present the advancements made so far regarding the immunochemical determination of cancer biomarkers by SERS. Thus, after a short introduction about the principles of both immunoassays and SERS, an extended presentation of up-to-date works regarding both single and multi-analyte determination of cancer biomarkers is presented. Finally, future perspectives on the field of SERS immunosensors for cancer markers detection are briefly discussed.</description><subject>Antibodies</subject><subject>Antigens</subject><subject>Biomarkers</subject><subject>Biosensors</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Diagnosis</subject><subject>Electromagnetism</subject><subject>Immunosensors</subject><subject>Laboratories</subject><subject>Light</subject><subject>Nanomaterials</subject><subject>Nanoparticles</subject><subject>Nanostructured materials</subject><subject>Radiation</subject><subject>Raman spectroscopy</subject><subject>Raman, Chandrasekhara V</subject><subject>Review</subject><subject>Spectrum analysis</subject><subject>Tumor markers</subject><issn>1996-1944</issn><issn>1996-1944</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkVtr3DAQhUVpaEKyL_kBZaEvpbCJRmPZ1lMJmyskBLrNs5DlUerUllLJLuTfR8vmWio9SBx9c8TMYWwf-AGi4oeDgRI4Vogf2A4oVS5AFcXHN_dtNkvpjueFCLVQn9g2VqIALPkOO1yd_FjNL4Zh8iGRTyGmuQtxvjTeUpxfmfibsnRMI9mxC36PbTnTJ5o9nbvs5vTk5_J8cXl9drE8ulzYoirGBZUkLEDTOqidQTRGOWEqwyWVbZ011TjXKCBZlsa1BAJRKi5MI6HmbYW77PvG935qBmot-TGaXt_HbjDxQQfT6fcvvvulb8NfDVwI4Fxmh69PDjH8mSiNeuiSpb43nsKUtKgF51CUFc_ol3_QuzBFn_vLVB5hJWuEV-rW9KQ770L-2K5N9VEluVIgJWbq4D9U3i0NnQ2eXJf1dwXfNgU2hpQiuZcmget1xPo14gx_fjuWF_Q5UHwEgF2eQA</recordid><startdate>20230515</startdate><enddate>20230515</enddate><creator>Geka, Georgia</creator><creator>Kanioura, Anastasia</creator><creator>Likodimos, Vlassis</creator><creator>Gardelis, Spiros</creator><creator>Papanikolaou, Nikolaos</creator><creator>Kakabakos, Sotirios</creator><creator>Petrou, Panagiota</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>HCIFZ</scope><scope>JG9</scope><scope>KB.</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4288-6132</orcidid><orcidid>https://orcid.org/0000-0002-0102-769X</orcidid><orcidid>https://orcid.org/0000-0001-8340-8025</orcidid><orcidid>https://orcid.org/0000-0002-0043-3119</orcidid></search><sort><creationdate>20230515</creationdate><title>SERS Immunosensors for Cancer Markers Detection</title><author>Geka, Georgia ; Kanioura, Anastasia ; Likodimos, Vlassis ; Gardelis, Spiros ; Papanikolaou, Nikolaos ; Kakabakos, Sotirios ; Petrou, Panagiota</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-e6e2c11bdf18fa33aa9f2a7a05e6d818f9bffb91e566afde12335902ab5180d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibodies</topic><topic>Antigens</topic><topic>Biomarkers</topic><topic>Biosensors</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Diagnosis</topic><topic>Electromagnetism</topic><topic>Immunosensors</topic><topic>Laboratories</topic><topic>Light</topic><topic>Nanomaterials</topic><topic>Nanoparticles</topic><topic>Nanostructured materials</topic><topic>Radiation</topic><topic>Raman spectroscopy</topic><topic>Raman, Chandrasekhara V</topic><topic>Review</topic><topic>Spectrum analysis</topic><topic>Tumor markers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Geka, Georgia</creatorcontrib><creatorcontrib>Kanioura, Anastasia</creatorcontrib><creatorcontrib>Likodimos, Vlassis</creatorcontrib><creatorcontrib>Gardelis, Spiros</creatorcontrib><creatorcontrib>Papanikolaou, Nikolaos</creatorcontrib><creatorcontrib>Kakabakos, Sotirios</creatorcontrib><creatorcontrib>Petrou, Panagiota</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>SciTech Premium Collection</collection><collection>Materials Research Database</collection><collection>Materials Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Geka, Georgia</au><au>Kanioura, Anastasia</au><au>Likodimos, Vlassis</au><au>Gardelis, Spiros</au><au>Papanikolaou, Nikolaos</au><au>Kakabakos, Sotirios</au><au>Petrou, Panagiota</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SERS Immunosensors for Cancer Markers Detection</atitle><jtitle>Materials</jtitle><addtitle>Materials (Basel)</addtitle><date>2023-05-15</date><risdate>2023</risdate><volume>16</volume><issue>10</issue><spage>3733</spage><pages>3733-</pages><issn>1996-1944</issn><eissn>1996-1944</eissn><abstract>Early diagnosis and monitoring are essential for the effective treatment and survival of patients with different types of malignancy. To this end, the accurate and sensitive determination of substances in human biological fluids related to cancer diagnosis and/or prognosis, i.e., cancer biomarkers, is of ultimate importance. Advancements in the field of immunodetection and nanomaterials have enabled the application of new transduction approaches for the sensitive detection of single or multiple cancer biomarkers in biological fluids. Immunosensors based on surface-enhanced Raman spectroscopy (SERS) are examples where the special properties of nanostructured materials and immunoreagents are combined to develop analytical tools that hold promise for point-of-care applications. In this frame, the subject of this review article is to present the advancements made so far regarding the immunochemical determination of cancer biomarkers by SERS. Thus, after a short introduction about the principles of both immunoassays and SERS, an extended presentation of up-to-date works regarding both single and multi-analyte determination of cancer biomarkers is presented. Finally, future perspectives on the field of SERS immunosensors for cancer markers detection are briefly discussed.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37241360</pmid><doi>10.3390/ma16103733</doi><orcidid>https://orcid.org/0000-0002-4288-6132</orcidid><orcidid>https://orcid.org/0000-0002-0102-769X</orcidid><orcidid>https://orcid.org/0000-0001-8340-8025</orcidid><orcidid>https://orcid.org/0000-0002-0043-3119</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1996-1944 |
ispartof | Materials, 2023-05, Vol.16 (10), p.3733 |
issn | 1996-1944 1996-1944 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10221005 |
source | Full-Text Journals in Chemistry (Open access); Publicly Available Content (ProQuest); PubMed Central |
subjects | Antibodies Antigens Biomarkers Biosensors Cancer Care and treatment Diagnosis Electromagnetism Immunosensors Laboratories Light Nanomaterials Nanoparticles Nanostructured materials Radiation Raman spectroscopy Raman, Chandrasekhara V Review Spectrum analysis Tumor markers |
title | SERS Immunosensors for Cancer Markers Detection |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T02%3A24%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SERS%20Immunosensors%20for%20Cancer%20Markers%20Detection&rft.jtitle=Materials&rft.au=Geka,%20Georgia&rft.date=2023-05-15&rft.volume=16&rft.issue=10&rft.spage=3733&rft.pages=3733-&rft.issn=1996-1944&rft.eissn=1996-1944&rft_id=info:doi/10.3390/ma16103733&rft_dat=%3Cgale_pubme%3EA750991553%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-e6e2c11bdf18fa33aa9f2a7a05e6d818f9bffb91e566afde12335902ab5180d73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2819475831&rft_id=info:pmid/37241360&rft_galeid=A750991553&rfr_iscdi=true |